Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ| Date | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
|---|---|---|---|
| 6/30/2025 | $ 334.69M | $ 116.36M | 34.77% |
| 3/31/2025 | $ 315.45M | $ 119.07M | 37.75% |
| 12/31/2024 | $ 323.06M | $ 121.78M | 37.7% |
| 9/30/2024 | $ 321.1M | $ 124.49M | 38.77% |
| 6/30/2024 | $ 331.73M | $ 127.2M | 38.34% |
| 3/31/2024 | $ 336.62M | $ 129.91M | 38.59% |
| 12/31/2023 | $ 322.6M | $ 132.62M | 41.11% |
| 9/30/2023 | $ 327.78M | $ 135.33M | 41.29% |
| 6/30/2023 | $ 328.78M | $ 138.04M | 41.99% |
| 3/31/2023 | $ 321.36M | $ 140.75M | 43.8% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets Intang. to Assets for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 170.39M ]
(=) Intang. to Assets [ 0% ] Minimum
Sep 30, 2020
Maximum
Dec 31, 2021
Average
Median
| filtered constituents | 3.24K |
|---|---|
| min | 0% |
| max | 23.21% |
| average | 3.99% |
| median | 0.52% |
| std | 6.1% |